ArticleMolecular and cellular biochemistry2026

Therapeutic potential of combined PPARγ agonist and MEK inhibitor treatment in modulating lipid metabolism and adipogenic reprogramming of breast cancer cells.

Zeynep Doğru Köseoğlu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.